Reactions 1680, p186 - 2 Dec 2017 Thrombotic microangiopathy: 2 case reports In a study of 117 cancer patients, a 57-year-old man and a 74-year-old woman, developed thrombotic microangiopathy at the end of one year of interferon α therapy for chronic myeloid leukaemia and at the end of six months of sunitinib [sunitinib malate] therapy for gastric mesothelioma, respectively [routes, dosages and outcomes not stated]. In both the patients. light microscopy showed diffuse and severe endothelial damage with double contours and occlusion of capillary lumen, while electron microscopy of the glomerular capillary wall showed expansion of the subendothelial space by electron-lucent debris. Author comment: "The present study observed three biopsy-confirmed rare cases: [thrombotic microangiopathy] in a patient with [chronic myeloid leukaemia] taking interfon- [alpha] and in a patient with gastric mesothelioma taking sunitinib malate." Wang T, et al. Acute kidney injury in cancer patients and impedance cardiography- assisted renal replacement therapy: Experience from the onconephrology unit of a Chinese tertiary hospital. Experimental and Therapeutic Medicine 14: 5671-5677, No. 6, Dec 2017. Available from: URL: http://doi.org/10.3892/etm.2017.5244 - China 803285335 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera